Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in-line with other countries.
Drugmakers were the worst-performing sector in Japan on Monday, weighing on the benchmark Topix despite optimism for a US-China trade deal broadly boosting markets across the region. Chugai Pharmaceutical Co. dropped as much as 7.2%, the most in a month, with peers Daiichi Sankyo Co. and Takeda Pharmaceutical Co. losing around 5%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.